| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +20% |
| 3Y CAGR | +34% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +115% |
| 3Y CAGR | +57% |
| Fund name | AUM% |
|---|---|
| 1.98 | |
| 0.83 |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,627.60 -38.30 (0.82%) | 21,329.88 | 29.01 | 5.08 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,720.50 +9.30 (0.34%) | 20,606.39 | 30.39 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,868.00 -49.00 (0.71%) | 17,317.75 | 102.09 | 19.84 | ||
Natco PharmaNATCOPHARM | ₹843.25 -5.95 (0.70%) | 15,211.80 | 13.29 | 1.65 |